402 related articles for article (PubMed ID: 12662127)
1. Anxiolytics: past, present, and future agents.
Nemeroff CB
J Clin Psychiatry; 2003; 64 Suppl 3():3-6. PubMed ID: 12662127
[TBL] [Abstract][Full Text] [Related]
2. New molecular targets for antianxiety interventions.
Gorman JM
J Clin Psychiatry; 2003; 64 Suppl 3():28-35. PubMed ID: 12662131
[TBL] [Abstract][Full Text] [Related]
3. The emerging differential roles of GABAergic and antiglutamatergic agents in bipolar disorders.
Ketter TA; Wang PW
J Clin Psychiatry; 2003; 64 Suppl 3():15-20. PubMed ID: 12662129
[TBL] [Abstract][Full Text] [Related]
4. The role of GABA in anxiety disorders.
Lydiard RB
J Clin Psychiatry; 2003; 64 Suppl 3():21-7. PubMed ID: 12662130
[TBL] [Abstract][Full Text] [Related]
5. The role of GABA in the pathophysiology and treatment of anxiety disorders.
Nemeroff CB
Psychopharmacol Bull; 2003; 37(4):133-46. PubMed ID: 15131523
[TBL] [Abstract][Full Text] [Related]
6. Approaches to developing new anxiolytics and antidepressants.
Dubovsky SL
J Clin Psychiatry; 1993 May; 54 Suppl():75-83. PubMed ID: 8099580
[TBL] [Abstract][Full Text] [Related]
7. Mixed depression and anxiety: serotonin1A receptors as a common pharmacologic link.
Stahl SM
J Clin Psychiatry; 1997; 58 Suppl 8():20-6. PubMed ID: 9236732
[TBL] [Abstract][Full Text] [Related]
8. Magnetic resonance spectroscopy studies of GABA in neuropsychiatric disorders.
Chang L; Cloak CC; Ernst T
J Clin Psychiatry; 2003; 64 Suppl 3():7-14. PubMed ID: 12662128
[TBL] [Abstract][Full Text] [Related]
9. [Better cure for anxiety, sleep disorders, epilepsy?].
Korpi ER; Wisden W; Lüddens H
Lakartidningen; 1997 Sep; 94(39):3403-8. PubMed ID: 9379810
[TBL] [Abstract][Full Text] [Related]
10. Anxioselective anxiolytics: can less be more?
Basile AS; Lippa AS; Skolnick P
Eur J Pharmacol; 2004 Oct; 500(1-3):441-51. PubMed ID: 15464051
[TBL] [Abstract][Full Text] [Related]
11. GABAA receptors as targets for novel anxiolytic drugs.
Rupprecht R; Eser D; Zwanzger P; Möller HJ
World J Biol Psychiatry; 2006; 7(4):231-7. PubMed ID: 17071543
[TBL] [Abstract][Full Text] [Related]
12. Intra-periaqueductal gray matter injections of midazolam fail to alter anxiety in plus-maze experienced mice.
dos Reis LM; Canto-de-Souza A
Brain Res; 2008 Sep; 1231():93-102. PubMed ID: 18621039
[TBL] [Abstract][Full Text] [Related]
13. New anxiolytics in development.
Mosconi M; Chiamulera C; Recchia G
Int J Clin Pharmacol Res; 1993; 13(6):331-44. PubMed ID: 7916335
[TBL] [Abstract][Full Text] [Related]
14. Treatments for generalized anxiety disorder.
Struzik L; Vermani M; Coonerty-Femiano A; Katzman MA
Expert Rev Neurother; 2004 Mar; 4(2):285-94. PubMed ID: 15853570
[TBL] [Abstract][Full Text] [Related]
15. Role of GABA in memory and anxiety.
Kalueff A; Nutt DJ
Depress Anxiety; 1996-1997; 4(3):100-10. PubMed ID: 9166638
[TBL] [Abstract][Full Text] [Related]
16. Translocator protein (18 kDa) as a target for novel anxiolytics with a favourable side-effect profile.
Nothdurfter C; Rammes G; Baghai TC; Schüle C; Schumacher M; Papadopoulos V; Rupprecht R
J Neuroendocrinol; 2012 Jan; 24(1):82-92. PubMed ID: 21609361
[TBL] [Abstract][Full Text] [Related]
17. Role of gamma-aminobutyric acid in anxiety.
Enna SJ
Psychopathology; 1984; 17 Suppl 1():15-24. PubMed ID: 6143341
[TBL] [Abstract][Full Text] [Related]
18. [New problems in GABAergic pharmacology of anxiety].
Kaluev AV
Eksp Klin Farmakol; 1997; 60(5):3-7. PubMed ID: 9483395
[TBL] [Abstract][Full Text] [Related]
19. [Anxiety; pharmacological bases of treatment].
de Andrés Rodríguez-Trelles F
An R Acad Nac Med (Madr); 1981; 98(1):69-116. PubMed ID: 6115590
[No Abstract] [Full Text] [Related]
20. Nonbenzodiazepine anxiolytics: insights into possible mechanisms of action.
VanderMaelen CP; Taylor DP; Gehlbach G; Eison MS
Psychopharmacol Bull; 1986; 22(3):807-12. PubMed ID: 2879307
[No Abstract] [Full Text] [Related]
[Next] [New Search]
